Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Almotriptan malate for acute treatment of migraine
CTR20150070Phase 3Completed
- Sponsor
- Sunshine Novo
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of almotriptan in migraine, sponsored by Sunshine Novo. Started Apr 2015; status: completed.
02
Drugs
almotriptan
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20150070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150070.